BCL2L1 and hepatocellular carcinoma: For example, miR-125b was found to sensitize hepatocellular carcinoma (HCC) cells to chemotherapeutic treatment by directly targeting MCL-1, BCL-W and indirectly targeting BCL-XL [66].